Literature DB >> 20506255

UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo.

Hiroaki Kimura1, Claudia Lee, Katsuhiro Hayashi, Kensuke Yamauchi, Norio Yamamoto, Hiroyuki Tsuchiya, Katsuro Tomita, Michael Bouvet, Robert M Hoffman.   

Abstract

We investigated the cell-killing efficacy of UV light on cancer cells expressing GFP in the nucleus and RFP in the cytoplasm (dual-color cells). After exposure to various doses of UVA, UVB, or UVC, apoptotic and viable cells were quantitated under fluorescence microscopy using dual-color 143B human osteosarcoma cells, HT-1080 human fibrosarcoma cells, Lewis lung carcinoma (LLC), and XPA-1 human pancreatic cancer cells in vitro. UV-induced cancer cell death was wave-length and dose dependent, as well as cell-line dependent. After UVA exposure, most cells were viable even when the UV dose was increased up to 200 J/m(2). With UVB irradiation, cell death was observed with irradiation at 50 J/m(2). For UVC, as little as 25 J/m(2) UVC irradiation killed approximately 70% of the 143B dual-color cells. This dose of UVB or UVA had almost no effect on the cancer cells. UV-induced cancer cell death varied among the cell lines. Cell death began about 4 h after irradiation and continued until 10 h after irradiation. UVC exposure also suppressed cancer cell growth in nude mice in a model of minimal residual cancer (MRC). No apparent side effects of UVC exposure were observed. This study opens up the possibility of UVC treatment for MRC after surgical resection. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506255     DOI: 10.1002/jcb.22693

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate.

Authors:  Makoto Mitsunaga; Takahito Nakajima; Kohei Sano; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2012-03-08       Impact factor: 4.774

2.  Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.

Authors:  Takahito Nakajima; Kohei Sano; Makoto Mitsunaga; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Res       Date:  2012-07-16       Impact factor: 12.701

3.  The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.

Authors:  Kohei Sano; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2013-12-19       Impact factor: 6.261

Review 4.  Tumor imaging with multicolor fluorescent protein expression.

Authors:  Norio Yamamoto; Hiroyuki Tsuchiya; Robert M Hoffman
Journal:  Int J Clin Oncol       Date:  2011-02-25       Impact factor: 3.402

5.  Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate.

Authors:  Tadanobu Nagaya; Alexander P Gorka; Roger R Nani; Shuhei Okuyama; Fusa Ogata; Yasuhiro Maruoka; Peter L Choyke; Martin J Schnermann; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2017-12-13       Impact factor: 6.261

6.  Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.

Authors:  Kiyoto Takehara; Shuya Yano; Hiroshi Tazawa; Hiroyuki Kishimoto; Nobuhiro Narii; Hiroyuki Mizuguchi; Yasuo Urata; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-01-05       Impact factor: 4.534

7.  Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.

Authors:  Makoto Mitsunaga; Takahito Nakajima; Kohei Sano; Gabriela Kramer-Marek; Peter L Choyke; Hisataka Kobayashi
Journal:  BMC Cancer       Date:  2012-08-08       Impact factor: 4.430

8.  Cytotoxicity and radiosensitizing potency of Moscatilin in cancer cells at low radiation doses of X-ray and UV-C.

Authors:  Ipsita Pujari; Abitha Thomas; Jinsu Thomas; Niharika Jhawar; Kanive Parashiva Guruprasad; Padmalatha S Rai; Kapaettu Satyamoorthy; Vidhu Sankar Babu
Journal:  3 Biotech       Date:  2021-05-20       Impact factor: 2.406

9.  Oxidative Stress-Dependent Synergistic Antiproliferation, Apoptosis, and DNA Damage of Ultraviolet-C and Coral-Derived Sinularin Combined Treatment for Oral Cancer Cells.

Authors:  Sheng-Yao Peng; Jen-Yang Tang; Ruei-Nian Li; Hurng-Wern Huang; Chang-Yi Wu; Chien-Chih Chiu; Fang-Rong Chang; Hong-Wei Zhang; Yun-Jou Lee; Jyh-Horng Sheu; Hsueh-Wei Chang
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

10.  Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.

Authors:  Takahito Nakajima; Kohei Sano; Peter L Choyke; Hisataka Kobayashi
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.